Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice
Abstract Angiogenesis, as a core marker of cancer survival and growth, is integral to the processes of tumour growth, invasion and metastasis. In recent years, targeted angiogenesis treatment strategies have gradually become an important direction in cancer treatment. Single‐cell sequencing technolo...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Clinical and Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ctm2.70313 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849728699830632448 |
|---|---|
| author | Shuaixi Yang Yingshuai Fang Yangcheng Ma Fuqi Wang Yuhang Wang Jiachi Jia Yabing Yang Weipeng Sun Quanbo Zhou Zhen Li |
| author_facet | Shuaixi Yang Yingshuai Fang Yangcheng Ma Fuqi Wang Yuhang Wang Jiachi Jia Yabing Yang Weipeng Sun Quanbo Zhou Zhen Li |
| author_sort | Shuaixi Yang |
| collection | DOAJ |
| description | Abstract Angiogenesis, as a core marker of cancer survival and growth, is integral to the processes of tumour growth, invasion and metastasis. In recent years, targeted angiogenesis treatment strategies have gradually become an important direction in cancer treatment. Single‐cell sequencing technology can provide new insights into targeted angiogenesis by providing a deeper understanding of the heterogeneity of tumour endothelial cells and exploring the interactions between endothelial cells and surrounding cells in the tumour microenvironment. Here, we systematically review the research progress in endothelial cell pathophysiology and its endothelial‒mesenchymal transition and illustrate the heterogeneity of endothelial cells from a single‐cell perspective. Finally, we examine the contributions of different cell types within the tumour microenvironment in relation to tumour angiogenesis, as well as the latest progress and strategies in targeted angiogenesis therapy, hoping to provide useful insights into the clinical application of antiangiogenic treatment. Furthermore, a summary of the present progress in the development of potential angiogenesis inhibitors and the ongoing clinical trials for combination therapies is provided. Key points Angiogenesis plays a key role in tumour progression, invasion and metastasis, so strategies targeting angiogenesis are gradually becoming an important direction in cancer therapy. Interactions between endothelial cells and stromal cells and immune cells in the tumour microenvironment are significant in angiogenesis. The application of antiangiogenic immunotherapy and nanotechnology in antiangiogenic therapy provides a vital strategy for prolonging the survival of cancer patients. |
| format | Article |
| id | doaj-art-49b9b19fba324018b6cb438c8afb3320 |
| institution | DOAJ |
| issn | 2001-1326 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical and Translational Medicine |
| spelling | doaj-art-49b9b19fba324018b6cb438c8afb33202025-08-20T03:09:28ZengWileyClinical and Translational Medicine2001-13262025-04-01154n/an/a10.1002/ctm2.70313Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practiceShuaixi Yang0Yingshuai Fang1Yangcheng Ma2Fuqi Wang3Yuhang Wang4Jiachi Jia5Yabing Yang6Weipeng Sun7Quanbo Zhou8Zhen Li9Department of Colorectal Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaThe First Clinical School of Medicine Zhengzhou University Zhengzhou ChinaDepartment of Orthopedics The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaDepartment of Colorectal Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaDepartment of Colorectal Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaThe First Clinical School of Medicine Zhengzhou University Zhengzhou ChinaThe First Clinical School of Medicine Zhengzhou University Zhengzhou ChinaDepartment of Colorectal Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaDepartment of Colorectal Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaDepartment of Colorectal Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaAbstract Angiogenesis, as a core marker of cancer survival and growth, is integral to the processes of tumour growth, invasion and metastasis. In recent years, targeted angiogenesis treatment strategies have gradually become an important direction in cancer treatment. Single‐cell sequencing technology can provide new insights into targeted angiogenesis by providing a deeper understanding of the heterogeneity of tumour endothelial cells and exploring the interactions between endothelial cells and surrounding cells in the tumour microenvironment. Here, we systematically review the research progress in endothelial cell pathophysiology and its endothelial‒mesenchymal transition and illustrate the heterogeneity of endothelial cells from a single‐cell perspective. Finally, we examine the contributions of different cell types within the tumour microenvironment in relation to tumour angiogenesis, as well as the latest progress and strategies in targeted angiogenesis therapy, hoping to provide useful insights into the clinical application of antiangiogenic treatment. Furthermore, a summary of the present progress in the development of potential angiogenesis inhibitors and the ongoing clinical trials for combination therapies is provided. Key points Angiogenesis plays a key role in tumour progression, invasion and metastasis, so strategies targeting angiogenesis are gradually becoming an important direction in cancer therapy. Interactions between endothelial cells and stromal cells and immune cells in the tumour microenvironment are significant in angiogenesis. The application of antiangiogenic immunotherapy and nanotechnology in antiangiogenic therapy provides a vital strategy for prolonging the survival of cancer patients.https://doi.org/10.1002/ctm2.70313angiogenesisantiangiogenic therapycancerEndMTendothelial cells |
| spellingShingle | Shuaixi Yang Yingshuai Fang Yangcheng Ma Fuqi Wang Yuhang Wang Jiachi Jia Yabing Yang Weipeng Sun Quanbo Zhou Zhen Li Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice Clinical and Translational Medicine angiogenesis antiangiogenic therapy cancer EndMT endothelial cells |
| title | Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice |
| title_full | Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice |
| title_fullStr | Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice |
| title_full_unstemmed | Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice |
| title_short | Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice |
| title_sort | angiogenesis and targeted therapy in the tumour microenvironment from basic to clinical practice |
| topic | angiogenesis antiangiogenic therapy cancer EndMT endothelial cells |
| url | https://doi.org/10.1002/ctm2.70313 |
| work_keys_str_mv | AT shuaixiyang angiogenesisandtargetedtherapyinthetumourmicroenvironmentfrombasictoclinicalpractice AT yingshuaifang angiogenesisandtargetedtherapyinthetumourmicroenvironmentfrombasictoclinicalpractice AT yangchengma angiogenesisandtargetedtherapyinthetumourmicroenvironmentfrombasictoclinicalpractice AT fuqiwang angiogenesisandtargetedtherapyinthetumourmicroenvironmentfrombasictoclinicalpractice AT yuhangwang angiogenesisandtargetedtherapyinthetumourmicroenvironmentfrombasictoclinicalpractice AT jiachijia angiogenesisandtargetedtherapyinthetumourmicroenvironmentfrombasictoclinicalpractice AT yabingyang angiogenesisandtargetedtherapyinthetumourmicroenvironmentfrombasictoclinicalpractice AT weipengsun angiogenesisandtargetedtherapyinthetumourmicroenvironmentfrombasictoclinicalpractice AT quanbozhou angiogenesisandtargetedtherapyinthetumourmicroenvironmentfrombasictoclinicalpractice AT zhenli angiogenesisandtargetedtherapyinthetumourmicroenvironmentfrombasictoclinicalpractice |